OXB Honored at Esteemed Leadership Awards in Gene Therapy
OXB (LSE: OXB), a renowned player in the cell and gene therapy sector, recently received the prestigious Champion title in the ‘Cell & Gene Therapy’ category at the CDMO Leadership Awards Europe. This accolade was awarded at a ceremony held in Frankfurt, highlighting OXB's strong reputation for quality and innovation in the contract development and manufacturing organization (CDMO) landscape.
A Showcase of Quality and Innovation
The title of Champion is not just an award; it signifies OXB's exceptional performance as the highest-rated CDMO in its category, as determined by valuable feedback from biopharmaceutical professionals. This recognition underscores the organization’s ongoing commitment to excellence and innovation, attributes that are crucial as the demand for advanced CDMO services rises.
Strengthening OXB's Global Footprint
In recent years, OXB has witnessed significant growth, driven by an increasing demand for its end-to-end services tailored for various vector types. The company supports a diverse range of clients, all at different stages of their development journey, enhancing OXB’s position in the global market.
Dr. Sebastien Ribault's Commitment to Clients
Dr. Sebastien Ribault, Chief Business Officer of OXB, expressed gratitude for the recognition, stating, "We are honoured to receive this recognition from the CDMO Leadership Awards Europe. This award reflects the trust and satisfaction of our clients and the hard work of our teams across the UK, US, and France. As demand continues to grow, we remain dedicated to supporting our clients in delivering transformative therapies to patients around the world." His words reinforce OXB’s vision of making a difference in patients' lives through groundbreaking therapies.
The Impact of OXB's Services
OXB stands as a pioneer in the field of cell and gene therapy, with over 30 years of experience in developing viral vectors—the core element behind most therapies in this realm. The company partners with leading pharmaceutical and biotechnology organizations to push the boundaries of what is possible in viral vector development.
Viral Vector Expertise
With capabilities spanning the entire development process to commercialization, OXB provides clients with tailored solutions in viral vector manufacturing. Their advanced methodologies include a 4th generation lentiviral vector system known as the TetraVecta™ system, dual-plasmid systems for AAV production, and innovative perfusion processes implemented with process enhancers.
Continuous Commitment to High Standards
OXB is well-regarded for maintaining robust quality assurance systems, comprehensive analytical methods, and regulatory expertise. This dedication ensures that the therapies developed meet the necessary safety and efficacy standards, which is critical in the life sciences industry.
Expanding Their Global Network
As a malleable entity, OXB has established its global presence with development and manufacturing facilities strategically located in key regions, including the UK, France, and the US. This strategic positioning enables OXB to better serve its partnerships in various biopharmaceutical developments.
OXB's Awards and Recognition
Beyond the recent award, OXB is also a constituent of both the FTSE250 and FTSE4Good indices, indicating not just their financial stability, but also their commitment to ethical practices within the industry.
Frequently Asked Questions
What does the CDMO Leadership Award represent?
The CDMO Leadership Award recognizes excellence amongst contract development and manufacturing organizations in various categories, based on feedback from industry professionals.
How has OXB been recognized in the recent awards?
OXB was awarded the Champion title in the ‘Cell & Gene Therapy’ category, marking it as the highest-rated CDMO based on direct client feedback.
What are the key areas of expertise for OXB?
OXB specializes in viral vector development, offering expertise in lentivirus, adeno-associated virus (AAV), and adenovirus technologies with robust manufacturing capabilities.
How does OXB ensure quality in its services?
OXB maintains high-quality standards through rigorous quality assurance systems and a strong focus on regulatory compliance in their manufacturing processes.
Where are OXB's facilities located?
OXB operates facilities in Oxford, Lyon, Strasbourg, Bedford, and Durham, allowing them to effectively meet the needs of their global clientele.
